Table: Sapporo Clinical Lab -2024/25 parent results

Sapporo Clinical Laboratory

12/05/2025 07:35

May 12 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.94           17.33          18.45         9.26    
               (+3.5 pct)      (-1.6 pct)     (+2.8 pct)    (+4.3 pct) 
  Operating      539 mln         368 mln                               
               (+46.4 pct)     (-47.7 pct)                             
  Recurring      718 mln         598 mln        740 mln      375 mln   
               (+20.1 pct)     (-33.2 pct)    (+3.0 pct)   (+10.2 pct) 
  Net            476 mln         460 mln        501 mln      254 mln   
               (+3.5 pct)      (-2.4 pct)     (+5.3 pct)   (+10.2 pct) 
  EPS          152.24 yen      138.25 yen     160.76 yen    81.56 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T